P53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss

Ran Brosh, Rachel Sarig, Elad Bar Natan, Alina Molchadsky, Shalom Madar, Chamutal Bornstein, Yosef Buganim, Tirosh Shapira, Naomi Goldfinger, Ralf Paus, Varda Rotter

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

The p53 tumor suppressor coordinates a multitude of cellular and organismal processes and exerts its activities mainly by activation of gene transcription. Here we describe the transcriptional activation of ectodysplasin A2 receptor (EDA2R) by p53 in a variety of cell types and tissues. We demonstrate that treatment of cancer cells with the ligand EDA-A2, known to specifically activate EDA2R, results in p53-dependent cell death. Moreover, we show that EDA2R is transactivated by p53 during chemotherapy-induced hair-loss, although its presence is not necessary for this process. These data shed new light on the role of EDA2R in exerting p53 function.

Original languageEnglish (US)
Pages (from-to)2473-2477
Number of pages5
JournalFEBS letters
Volume584
Issue number11
DOIs
StatePublished - Jun 1 2010
Externally publishedYes

Keywords

  • Alopecia
  • Chemotherapy-induced alopecia
  • Cyclophosphamide
  • Knockout
  • XEDAR

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Fingerprint Dive into the research topics of 'P53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss'. Together they form a unique fingerprint.

  • Cite this

    Brosh, R., Sarig, R., Natan, E. B., Molchadsky, A., Madar, S., Bornstein, C., Buganim, Y., Shapira, T., Goldfinger, N., Paus, R., & Rotter, V. (2010). P53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss. FEBS letters, 584(11), 2473-2477. https://doi.org/10.1016/j.febslet.2010.04.058